• Company
• Celltrion-Icure applied for permission for Donepezil patch
• by Chon, Seung-Hyun Apr 16, 2021 06:02am

• Company
• Vyndamax tries RSA after failing essential drug designation
• by Eo, Yun-Ho Apr 15, 2021 05:56am

• Policy
• SK's Cosca 25mg was first approved
• by Lee, Tak-Sun Apr 15, 2021 05:56am

• Company
• Measures for the reimbursement of advanced therapies
• by Apr 15, 2021 05:56am

• Policy
• Moderna's COVID-19 vaccine has been applied for approval
• by Lee, Tak-Sun Apr 15, 2021 05:56am

• Opinion
• [Reporter's view] Expensive vaccine sovereignty
• by Apr 15, 2021 05:56am

• Company
• “The framework to list ultra-expensive new drugs exists"
• by Eo, Yun-Ho Apr 14, 2021 06:07am

• Company
• Generic for Eliquis, stop selling after supreme court loss
• by Kim, Jin-Gu Apr 14, 2021 06:07am

• Policy
• NHIS and choline alfoscerate makers fail to reach agreement
• by Kim, Jung-Ju Apr 14, 2021 06:06am

• Policy
• MFDS to support domestic vaccine for COVID-19
• by Lee, Tak-Sun Apr 14, 2021 06:06am